Text Size

Prevalence of Type 2 Diabetes Mellitus in Ethiopian Community in Israel: an Update

The recruitment status of this study is unknown because the information has not been verified recently.
Verified November 2006 by HaEmek Medical Center, Israel.
Recruitment status was  Active, not recruiting
Sponsor:
Information provided by:
HaEmek Medical Center, Israel
ClinicalTrials.gov Identifier:
NCT00399347
First received: November 12, 2006
Last updated: NA
Last verified: November 2006
History: No changes posted
  Purpose

The prevalence and incidence of diabetes has been reported to vary among populations.Immigrants groups as that have undergone significant life-style changes tend to develop diabetes within a short time. The aim of the study is to assess the prevalence of diabetes mellitus in Ethiopian population ,15-20 years after immigration in Israel.


Condition
Diabetes Mellitus

Study Type: Observational
Study Design: Observational Model: Defined Population
Primary Purpose: Screening
Time Perspective: Cross-Sectional
Time Perspective: Retrospective
Official Title: Prevalence of Diabetes Mellitus in Ethiopian Community in Israel: an Update

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by HaEmek Medical Center, Israel:

Estimated Enrollment: 500
Study Start Date: January 2005
Estimated Study Completion Date: December 2005
Detailed Description:

The study will be conducted in three primary care clinics of the Jezreel Valley (Omer, Givat Hamore and Afula Illit). The computerized medical charts of 500 Ethiopian adults will be reviewed. The following information will be obtained: age, date of arrival in Israel, known history of diabetes, hyperlipidemia, hypertension or other disease, drug therapy, body weight, blood pressure. Following laboratory data will be retrieved: blood glucose, HbA1c, lipid levels , creatinine and uric acid. The criteria used for the definition of diabetes will be based on the criteria proposed by the American Diabetes Association .

  Eligibility

Ages Eligible for Study:   33 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Male and female Ethiopians Jews who immigrate in Israel in 1991 and were 18 years old or more at immigration.

Exclusion Criteria:

  • Type 1 diabetes Mellitus
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00399347

Locations
Israel
Primary care clinics
Afula, Israel
Sponsors and Collaborators
HaEmek Medical Center, Israel
Investigators
Principal Investigator: Avraham Ishay MD HaEmek Medical Center, Afula, Israel
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00399347     History of Changes
Other Study ID Numbers: 4940706
Study First Received: November 12, 2006
Last Updated: November 12, 2006
Health Authority: Israel: Ethics Commission

Keywords provided by HaEmek Medical Center, Israel:
Diabetes Mellitus, prevalence , Ethiopians Jews, Israel

Additional relevant MeSH terms:
Diabetes Mellitus
Diabetes Mellitus, Type 2
Glucose Metabolism Disorders
Metabolic Diseases
Endocrine System Diseases

ClinicalTrials.gov processed this record on May 19, 2013